IL-21 Signaling in Immunity

F1000Research

Volumn 5, Issue , 2016, Pages

  Leonard, Warren J ^a   Wan, Chi Keung ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 21 RECEPTOR; RITUXIMAB; SORAFENIB; STAT3 PROTEIN;

ADOPTIVE TRANSFER; ANTINEOPLASTIC ACTIVITY; AUTOIMMUNE DISEASE; B CELL LYMPHOMA; CAPILLARY LEAK SYNDROME; COMPLEX FORMATION; CYTOKINE PRODUCTION; DRUG MECHANISM; DRUG MEGADOSE; GENE MUTATION; HUMAN; IL21 GENE; IL21R GENE; IMMUNE DEFICIENCY; IMMUNITY; IMMUNOTHERAPY; KIDNEY METASTASIS; METASTATIC MELANOMA; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; TUMOR MICROENVIRONMENT; VIRUS INFECTION;

EID: 84964411209     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.7634.1     Document Type: Review

References (100)

1. Spolski R Leonard WJ: Interleukin-21: a double-edged sword with therapeutic potential. Nat Rev Drug Discov. 2014;13(5):379-395. 24751819 10.1038/nrd4296
2. Rochman Y Spolski R Leonard WJ: New insights into the regulation of T cells by gamma(c) family cytokines. Nat Rev Immunol. 2009;9(7):480-490. 19543225 10.1038/nri2580 2814538
3. Recher M Berglund LJ Avery DT: IL-21 is the primary common γ chain-binding cytokine required for human B-cell differentiation in vivo. Blood. 2011;118(26):6824-6835. 22039266 10.1182/blood-2011-06-362533 3338166
4. Ozaki K Spolski R Feng CG: A critical role for IL-21 in regulating immunoglobulin production. Science. 2002;298(5598):1630-1634. 12446913 10.1126/science.1077002 F1000 Recommendation
5. Li P Spolski R Liao W: Complex interactions of transcription factors in mediating cytokine biology in T cells. Immunol Rev. 2014;261(1):141-156. 25123282 10.1111/imr.12199 4174316
6. Kotlarz D Ziȩtara N Uzel G: Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome. J Exp Med. 2013;210(3):433-443. 23440042 10.1084/jem.20111229 3600901 F1000 Recommendation
7. Salzer E Kansu A Sic H: Early-onset inflammatory bowel disease and common variable immunodeficiency-like disease caused by IL-21 deficiency. J Allergy Clin Immunol. 2014;133(6):1651-9.e12. 24746753 10.1016/j.jaci.2014.02.034 F1000 Recommendation
8. Erman B Bilic I Hirschmugl T: Combined immunodeficiency with CD4 lymphopenia and sclerosing cholangitis caused by a novel loss-of-function mutation affecting IL21R. Haematologica. 2015;100(6):e216-9. 25769540 10.3324/haematol.2014.120980 4450632
9. Stepensky P Keller B Abuzaitoun O: Extending the clinical and immunological phenotype of human interleukin-21 receptor deficiency. Haematologica. 2015;100(2):e72-6. 25398835 10.3324/haematol.2014.112508
10. Zeng R Spolski R Casas E: The molecular basis of IL-21-mediated proliferation. Blood. 2007;109(10):4135-4142. 17234735 10.1182/blood-2006-10-054973 1885510
11. Siegel AM Heimall J Freeman AF: A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory. Immunity. 2011;35(5):806-818. 22118528 10.1016/j.immuni.2011.09.016 3228524 F1000 Recommendation
12. Avery DT Deenick EK Ma CS: B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans. J Exp Med. 2010;207(1):155-171. 20048285 10.1084/jem.20091706 2812540 F1000 Recommendation
13. Ma CS Avery DT Chan A: Functional STAT3 deficiency compromises the generation of human T follicular helper cells. Blood. 2012;119(17):3997-4008. 22403255 10.1182/blood-2011-11-392985 3355712
14. Ives ML Ma CS Palendira U: Signal transducer and activator of transcription 3 ( STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8 + T-cell memory formation and function. J Allergy Clin Immunol. 2013;132(2):400-11.e9. 23830147 10.1016/j.jaci.2013.05.029 3785237
15. Deenick EK Avery DT Chan A: Naive and memory human B cells have distinct requirements for STAT3 activation to differentiate into antibody-secreting plasma cells. J Exp Med. 2013;210(12):2739-2753. 24218138 10.1084/jem.20130323 3832925
16. Huber M Brüstle A Reinhard K: IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype. Proc Natl Acad Sci U S A. 2008;105(52):20846-20851. 19088203 10.1073/pnas.0809077106 2634912 F1000 Recommendation
17. Kwon H Thierry-Mieg D Thierry-Mieg J: Analysis of interleukin-21-induced Prdm1 gene regulation reveals functional cooperation of STAT3 and IRF4 transcription factors. Immunity. 2009;31(6):941-952. 20064451 10.1016/j.immuni.2009.10.008 3272079
18. Li P Spolski R Liao W: BATF-JUN is critical for IRF4-mediated transcription in T cells. Nature. 2012;490(7421):543-546. 22992523 10.1038/nature11530 3537508 F1000 Recommendation
19. Tussiwand R Lee WL Murphy TL: Compensatory dendritic cell development mediated by BATF-IRF interactions. Nature. 2012;490(7421):502-507. 22992524 10.1038/nature11531 3482832 F1000 Recommendation
20. Glasmacher E Agrawal S Chang AB: A genomic regulatory element that directs assembly and function of immune-specific AP-1-IRF complexes. Science. 2012;338(6109):975-980. 22983707 10.1126/science.1228309 F1000 Recommendation
21. Yeste A Mascanfroni ID Nadeau M: IL-21 induces IL-22 production in CD4 + T cells. Nat Commun. 2014;5: 3753. 24796415 10.1038/ncomms4753 4157605
22. Zhou L Ivanov II Spolski R: IL-6 programs T H-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol. 2007;8(9):967-974. 17581537 10.1038/ni1488 F1000 Recommendation
23. Yang XO Panopoulos AD Nurieva R: STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem. 2007;282(13):9358-9363. 17277312 10.1074/jbc.C600321200 F1000 Recommendation
24. Milner JD Brenchley JM Laurence A: Impaired T H17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature. 2008;452(7188):773-776. 18337720 10.1038/nature06764 2864108 F1000 Recommendation
25. Ozaki K Spolski R Ettinger R: Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J Immunol. 2004;173(9):5361-5371. 15494482 10.4049/jimmunol.173.9.5361
26. Sowerwine KJ Holland SM Freeman AF: Hyper-IgE syndrome update. Ann N Y Acad Sci. 2012;1250:25-32. 22268731 10.1111/j.1749-6632.2011.06387.x 4103910
27. Sutherland AP Joller N Michaud M: IL-21 promotes CD8 + CTL activity via the transcription factor T-bet. J Immunol. 2013;190(8):3977-3984. 23479229 10.4049/jimmunol.1201730
28. Wan CK Andraski AB Spolski R: Opposing roles of STAT1 and STAT3 in IL-21 function in CD4 + T cells. Proc Natl Acad Sci U S A. 2015;112(30):9394-9399. 26170288 10.1073/pnas.1511711112 4522759
29. Liu L Okada S Kong XF: Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med. 2011;208(8):1635-1648. 21727188 10.1084/jem.20110958 3149226 F1000 Recommendation
30. Romberg N Morbach H Lawrence MG: Gain-of-function STAT1 mutations are associated with PD-L1 overexpression and a defect in B-cell survival. J Allergy Clin Immunol. 2013;131(6):1691-1693. 23403048 10.1016/j.jaci.2013.01.004 3672340
31. Di Fusco D Izzo R Figliuzzi MM: IL-21 as a therapeutic target in inflammatory disorders. Expert Opin Ther Targets. 2014;18(11):1329-1338. 25162763 10.1517/14728222.2014.945426
32. Glocker EO Frede N Perro M: Infant colitis--it's in the genes. Lancet. 2010;376(9748):1272. 20934598 10.1016/S0140-6736(10)61008-2
33. Glocker EO Kotlarz D Boztug K: Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med. 2009;361(21):2033-2045. 19890111 10.1056/NEJMoa0907206 2787406 F1000 Recommendation
34. Spolski R Kim HP Zhu W: IL-21 mediates suppressive effects via its induction of IL-10. J Immunol. 2009;182(5):2859-2867. 19234181 10.4049/jimmunol.0802978 2756221
35. Pot C Jin H Awasthi A: Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J Immunol. 2009;183(2):797-801. 19570826 10.4049/jimmunol.0901233 2768608 F1000 Recommendation
36. Doganci A Birkholz J Gehring S: In the presence of IL-21 human cord blood T cells differentiate to IL-10-producing Th1 but not Th17 or Th2 cells. Int Immunol. 2013;25(3):157-169. 23097377 10.1093/intimm/dxs097
37. Good KL Bryant VL Tangye SG: Kinetics of human B cell behavior and amplification of proliferative responses following stimulation with IL-21. J Immunol. 2006;177(8):5236-5247. 17015709 10.4049/jimmunol.177.8.5236
38. Yoshizaki A Miyagaki T DiLillo DJ: Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature. 2012;491(7423):264-268. 23064231 10.1038/nature11501 3493692 F1000 Recommendation
39. Lindner S Dahlke K Sontheimer K: Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells. Cancer Res. 2013;73(8):2468-2479. 23384943 10.1158/0008-5472.CAN-12-3450
40. Jin H Carrio R Yu A: Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or Bim-dependent apoptosis. J Immunol. 2004;173(1):657-665. 15210829 10.4049/jimmunol.173.1.657
41. Mehta DS Wurster AL Whitters MJ: IL-21 induces the apoptosis of resting and activated primary B cells. J Immunol. 2003;170(8):4111-4118. 12682241 10.4049/jimmunol.170.8.4111
42. Wan CK Oh J Li P: The cytokines IL-21 and GM-CSF have opposing regulatory roles in the apoptosis of conventional dendritic cells. Immunity. 2013;38(3):514-527. 23453633 10.1016/j.immuni.2013.02.011 3705920 F1000 Recommendation
43. Ettinger R Sims GP Fairhurst AM: IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J Immunol. 2005;175(12):7867-7879. 16339522 10.4049/jimmunol.175.12.7867
44. Avery DT Ma CS Bryant VL: STAT3 is required for IL-21-induced secretion of IgE from human naive B cells. Blood. 2008;112(5):1784-1793. 18579794 10.1182/blood-2008-02-142745
45. Lenardo MJ: Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature. 1991;353(6347):858-861. 1944559 10.1038/353858a0
46. Brandt K Bulfone-Paus S Foster DC: Interleukin-21 inhibits dendritic cell activation and maturation. Blood. 2003;102(12):4090-4098. 12893770 10.1182/blood-2003-03-0669
47. Brandt K Bulfone-Paus S Jenckel A: Interleukin-21 inhibits dendritic cell-mediated T cell activation and induction of contact hypersensitivity in vivo. J Invest Dermatol. 2003;121(6):1379-1382. 14675186 10.1046/j.1523-1747.2003.12603.x
48. Wan CK Li P Spolski R: IL-21-mediated non-canonical pathway for IL-1β production in conventional dendritic cells. Nat Commun. 2015;6: 7988. 26269257 10.1038/ncomms8988 4555999
49. Spolski R Kashyap M Robinson C: IL-21 signaling is critical for the development of type I diabetes in the NOD mouse. Proc Natl Acad Sci U S A. 2008;105(37):14028-14033. 18779574 10.1073/pnas.0804358105 2544573 F1000 Recommendation
50. Sutherland AP Van Belle T Wurster AL: Interleukin-21 is required for the development of type 1 diabetes in NOD mice. Diabetes. 2009;58(5):1144-1155. 19208913 10.2337/db08-0882 2671036 F1000 Recommendation
51. Bubier JA Sproule TJ Foreman O: A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB- Yaa mice. Proc Natl Acad Sci U S A. 2009;106(5):1518-1523. 19164519 10.1073/pnas.0807309106 2635818
52. Wang L Yu CR Kim HP: Key role for IL-21 in experimental autoimmune uveitis. Proc Natl Acad Sci U S A. 2011;108(23):9542-9547. 21593413 10.1073/pnas.1018182108 3111309
53. Nakou M Papadimitraki ED Fanouriakis A: Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells. Clin Exp Rheumatol. 2013;31(2):172-179. 23137515
54. Rasmussen TK Andersen T Hvid M: Increased interleukin 21 (IL-21) and IL-23 are associated with increased disease activity and with radiographic status in patients with early rheumatoid arthritis. J Rheumatol. 2010;37(10):2014-2020. 20682664 10.3899/jrheum.100259
55. McPhee CG Bubier JA Sproule TJ: IL-21 is a double-edged sword in the systemic lupus erythematosus-like disease of BXSB. Yaa mice. J Immunol. 2013;191(9):4581-4588. 24078696 10.4049/jimmunol.1300439 3807747
56. Croce M Rigo V Ferrini S: IL-21: a pleiotropic cytokine with potential applications in oncology. J Immunol Res. 2015;2015: 696578. 25961061 10.1155/2015/696578 4413888
57. Kasaian MT Whitters MJ Carter LL: IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity. 2002;16(4):559-569. 11970879 10.1016/S1074-7613(02)00295-9 F1000 Recommendation
58. Brady J Hayakawa Y Smyth MJ: IL-21 induces the functional maturation of murine NK cells. J Immunol. 2004;172(4):2048-2058. 14764669 10.4049/jimmunol.172.4.2048
59. Wang G Tschoi M Spolski R: In vivo antitumor activity of interleukin 21 mediated by natural killer cells. Cancer Res. 2003;63(24):9016-9022. 14695220
60. Zeng R Spolski R Finkelstein SE: Synergy of IL-21 and IL-15 in regulating CD8 + T cell expansion and function. J Exp Med. 2005;201(1):139-148. 15630141 10.1084/jem.20041057 2212766 F1000 Recommendation
61. Di Carlo E Comes A Orengo AM: IL-21 induces tumor rejection by specific CTL and IFN-gamma-dependent CXC chemokines in syngeneic mice. J Immunol. 2004;172(3):1540-1547. 14734732 10.4049/jimmunol.172.3.1540
62. Ma HL Whitters MJ Konz RF: IL-21 activates both innate and adaptive immunity to generate potent antitumor responses that require perforin but are independent of IFN-gamma. J Immunol. 2003;171(2):608-615. 12847225 10.4049/jimmunol.171.2.608 F1000 Recommendation
63. Ugai S Shimozato O Kawamura K: Expression of the interleukin-21 gene in murine colon carcinoma cells generates systemic immunity in the inoculated hosts. Cancer Gene Ther. 2003;10(3):187-192. 12637939 10.1038/sj.cgt.7700552
64. Kumano M Hara I Furukawa J: Interleukin-21 activates cytotoxic T lymphocytes and natural killer cells to generate antitumor response in mouse renal cell carcinoma. J Urol. 2007;178(4 Pt 1):1504-1509. 17707061 10.1016/j.juro.2007.05.115
65. Xu M Liu M Du X: Intratumoral Delivery of IL-21 Overcomes Anti-Her2/Neu Resistance through Shifting Tumor-Associated Macrophages from M2 to M1 Phenotype. J Immunol. 2015;194(10):4997-5006. 25876763 10.4049/jimmunol.1402603 F1000 Recommendation
66. Petrella TM Tozer R Belanger K: Interleukin-21 has activity in patients with metastatic melanoma: a phase II study. J Clin Oncol. 2012;30(27):3396-3401. 22915661 10.1200/JCO.2011.40.0655 F1000 Recommendation
67. Bhatia S Curti B Ernstoff MS: Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase 1/2 study. J Immunother Cancer. 2014;2:2. 24829759 10.1186/2051-1426-2-2 4019894
68. Sarosiek KA Malumbres R Nechushtan H: Novel IL-21 signaling pathway up-regulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas. Blood. 2010;115(3):570-580. 19965678 10.1182/blood-2009-08-239996 2810990 F1000 Recommendation
69. Bhatt S Matthews J Parvin S: Direct and immune-mediated cytotoxicity of interleukin-21 contributes to antitumor effects in mantle cell lymphoma. Blood. 2015;126(13):1555-1564. 26194763 10.1182/blood-2015-01-624585 4582332
70. Gelebart P Zak Z Anand M: Interleukin-21 effectively induces apoptosis in mantle cell lymphoma through a STAT1-dependent mechanism. Leukemia. 2009;23(10):1836-1846. 19494838 10.1038/leu.2009.100
71. de Totero D Meazza R Zupo S: Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering and mediates proapoptotic signals in chronic lymphocytic leukemia B cells. Blood. 2006;107(9):3708-3715. 16391014 10.1182/blood-2005-09-3535
72. Gowda A Roda J Hussain SR: IL-21 mediates apoptosis through up-regulation of the BH3 family member BIM and enhances both direct and antibody-dependent cellular cytotoxicity in primary chronic lymphocytic leukemia cells in vitro. Blood. 2008;111(9):4723-4730. 18182577 10.1182/blood-2007-07-099531 2343602
73. Timmerman JM Byrd JC Andorsky DJ: A phase I dose-finding trial of recombinant interleukin-21 and rituximab in relapsed and refractory low grade B-cell lymphoproliferative disorders. Clin Cancer Res. 2012;18(20):5752-5760. 22893631 10.1158/1078-0432.CCR-12-0456
74. Sivakumar PV Garcia R Waggie KS: Comparison of vascular leak syndrome in mice treated with IL21 or IL2. Comp Med. 2013;63(1):13-21. 23561933 3567372
75. Chapuis AG Ragnarsson GB Nguyen HN: Transferred WT1-reactive CD8 + T cells can mediate antileukemic activity and persist in post-transplant patients. Sci Transl Med. 2013;5(174):174ra27. 23447018 10.1126/scitranslmed.3004916 3678970 F1000 Recommendation
76. Elsaesser H Sauer K Brooks DG: IL-21 is required to control chronic viral infection. Science. 2009;324(5934):1569-1572. 19423777 10.1126/science.1174182 2830017 F1000 Recommendation
77. Yi JS Du M Zajac AJ: A vital role for interleukin-21 in the control of a chronic viral infection. Science. 2009;324(5934):1572-1576. 19443735 10.1126/science.1175194 2736049 F1000 Recommendation
78. Fröhlich A Kisielow J Schmitz I: IL-21R on T cells is critical for sustained functionality and control of chronic viral infection. Science. 2009;324(5934):1576-1580. 19478140 10.1126/science.1172815 F1000 Recommendation
79. Schmitz I Schneider C Fröhlich A: IL-21 restricts virus-driven Treg cell expansion in chronic LCMV infection. PLoS Pathog. 2013;9(5):e1003362. 23696736 10.1371/journal.ppat.1003362 3656089
80. Novy P Huang X Leonard WJ: Intrinsic IL-21 signaling is critical for CD8 T cell survival and memory formation in response to vaccinia viral infection. J Immunol. 2011;186(5):2729-2738. 21257966 10.4049/jimmunol.1003009 3059504 F1000 Recommendation
81. Cui W Liu Y Weinstein JS: An interleukin-21-interleukin-10-STAT3 pathway is critical for functional maturation of memory CD8 + T cells. Immunity. 2011;35(5):792-805. 22118527 10.1016/j.immuni.2011.09.017 3431922 F1000 Recommendation
82. Rasheed MA Latner DR Aubert RD: Interleukin-21 is a critical cytokine for the generation of virus-specific long-lived plasma cells. J Virol. 2013;87(13):7737-7746. 23637417 10.1128/JVI.00063-13 3700268
83. Iannello A Tremblay C Routy JP: Decreased levels of circulating IL-21 in HIV-infected AIDS patients: correlation with CD4 + T-cell counts. Viral Immunol. 2008;21(3):385-388. 18788946 10.1089/vim.2008.0025
84. Iannello A Boulassel MR Samarani S: Dynamics and consequences of IL-21 production in HIV-infected individuals: a longitudinal and cross-sectional study. J Immunol. 2010;184(1):114-126. 19949086 10.4049/jimmunol.0901967
85. Chevalier MF Jülg B Pyo A: HIV-1-specific interleukin-21 + CD4 + T cell responses contribute to durable viral control through the modulation of HIV-specific CD8 + T cell function. J Virol. 2011;85(2):733-741. 21047960 10.1128/JVI.02030-10 3020027
86. Williams LD Amatya N Bansal A: Immune activation is associated with CD8 T cell interleukin-21 production in HIV-1-infected individuals. J Virol. 2014;88(17):10259-10263. 24942568 10.1128/JVI.00764-14 4136345
87. Williams LD Bansal A Sabbaj S: Interleukin-21-producing HIV-1-specific CD8 T cells are preferentially seen in elite controllers. J Virol. 2011;85(5):2316-2324. 21159862 10.1128/JVI.01476-10 3067790 F1000 Recommendation
88. Perreau M Savoye AL De Crignis E: Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production. J Exp Med. 2013;210(1):143-156. 23254284 10.1084/jem.20121932 3549706 F1000 Recommendation
89. Cubas RA Mudd JC Savoye AL: Inadequate T follicular cell help impairs B cell immunity during HIV infection. Nat Med. 2013;19(4):494-499. 23475201 10.1038/nm.3109 3843317 F1000 Recommendation
90. Iannello A Boulassel MR Samarani S: IL-21 enhances NK cell functions and survival in healthy and HIV-infected patients with minimal stimulation of viral replication. J Leukoc Biol. 2010;87(5):857-867. 20103765 10.1189/jlb.1009701
91. Strbo N de Armas L Liu H: IL-21 augments natural killer effector functions in chronically HIV-infected individuals. AIDS. 2008;22(13):1551-1560. 18670213 10.1097/QAD.0b013e3283089367 2665999
92. Pallikkuth S Rogers K Villinger F: Interleukin-21 administration to rhesus macaques chronically infected with simian immunodeficiency virus increases cytotoxic effector molecules in T cells and NK cells and enhances B cell function without increasing immune activation or viral replication. Vaccine. 2011;29(49):9229-9238. 21996099 10.1016/j.vaccine.2011.09.118 3260006 F1000 Recommendation
93. Pallikkuth S Micci L Ende ZS: Maintenance of intestinal Th17 cells and reduced microbial translocation in SIV-infected rhesus macaques treated with interleukin (IL)-21. PLoS Pathog. 2013;9(7):e1003471. 23853592 10.1371/journal.ppat.1003471 3701718 F1000 Recommendation
94. Ortiz AM Klase ZA DiNapoli SR: IL-21 and probiotic therapy improve Th17 frequencies, microbial translocation, and microbiome in ARV-treated, SIV-infected macaques. Mucosal Immunol. 2015. 26286233 10.1038/mi.2015.75
95. Micci L Ryan ES Fromentin R: Interleukin-21 combined with ART reduces inflammation and viral reservoir in SIV-infected macaques. J Clin Invest. 2015;125(12):4497-4513. 26551680 10.1172/JCI81400 4665780
96. Hippen KL Bucher C Schirm DK: Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes. Blood. 2012;119(2):619-628. 22077059 10.1182/blood-2011-07-368027 3257019
97. Hanash AM Kappel LW Yim NL: Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL. Blood. 2011;118(2):446-455. 21596854 10.1182/blood-2010-07-294785 3138694
98. Bucher C Koch L Vogtenhuber C: IL-21 blockade reduces graft-versus-host disease mortality by supporting inducible T regulatory cell generation. Blood. 2009;114(26):5375-5384. 19843883 10.1182/blood-2009-05-221135 2796140
99. Meguro A Ozaki K Hatanaka K: Lack of IL-21 signal attenuates graft-versus-leukemia effect in the absence of CD8 T-cells. Bone Marrow Transplant. 2011;46(12):1557-1565. 21258423 10.1038/bmt.2010.342 3401481
100. Meguro A Ozaki K Oh I: IL-21 is critical for GVHD in a mouse model. Bone Marrow Transplant. 2010;45(4):723-729. 19718060 10.1038/bmt.2009.223 3403836